Research ArticleArticle
First-Pass Midazolam Metabolism Catalyzed by 1α,25-Dihydroxy Vitamin D3-Modified Caco-2 Cell Monolayers
Jeannine M. Fisher, Steven A. Wrighton, Paul B. Watkins, Phyllissa Schmiedlin-Ren, Justina C. Calamia, Danny D. Shen, Kent L. Kunze and Kenneth E. Thummel
Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 1134-1142;
Jeannine M. Fisher
Steven A. Wrighton
Paul B. Watkins
Phyllissa Schmiedlin-Ren
Justina C. Calamia
Danny D. Shen
Kent L. Kunze
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 2
1 May 1999
Research ArticleArticle
First-Pass Midazolam Metabolism Catalyzed by 1α,25-Dihydroxy Vitamin D3-Modified Caco-2 Cell Monolayers
Jeannine M. Fisher, Steven A. Wrighton, Paul B. Watkins, Phyllissa Schmiedlin-Ren, Justina C. Calamia, Danny D. Shen, Kent L. Kunze and Kenneth E. Thummel
Journal of Pharmacology and Experimental Therapeutics May 1, 1999, 289 (2) 1134-1142;
Research ArticleArticle
First-Pass Midazolam Metabolism Catalyzed by 1α,25-Dihydroxy Vitamin D3-Modified Caco-2 Cell Monolayers
Jeannine M. Fisher, Steven A. Wrighton, Paul B. Watkins, Phyllissa Schmiedlin-Ren, Justina C. Calamia, Danny D. Shen, Kent L. Kunze and Kenneth E. Thummel
Journal of Pharmacology and Experimental Therapeutics May 1, 1999, 289 (2) 1134-1142;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement